Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?


Drug Profile


Alternative Names: Arveles; D 1158; Desketo; Dexketoprofen trometamol; Dexketoprofen tromethamine; Dextroketoprofen; Enangel; Enantyum; Keral; Ketesse; LM 1158; Nosatel; Quiralam; Quirgel; S-ketoprofen; Stadium; Sympal; Viaxal

Latest Information Update: 29 Sep 2014

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Menarini
  • Developer Berlin Chemie; Celltech Group; Istituto Lusofarmaco; Malesci; Menarini
  • Class Nonsteroidal anti-inflammatories; Phenylpropionates; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors; Prostaglandin synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Inflammation; Musculoskeletal pain; Pain

Most Recent Events

  • 01 May 2014 Menarini completes a phase I bioavailability trial in volunteers in United Kingdom (NCT02209454)
  • 01 Apr 2014 Menarini initiates a phase I bioavailability trial in volunteers in United Kingdom (NCT02209454)
  • 30 Dec 2003 A case report has been added to the adverse events section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top